Nitrosourea

Nitrosourea
Skeletal formula of a minor tautomer of nitrosourea	Ball and stick model a minor tautomer of nitrosourea
Names
	IUPAC name Nitrosourea
Identifiers
CAS Number	13010-20-3 ;
3D model (JSmol)	Interactive image; Interactive image;
ChemSpider	94772 ;
PubChem CID	105035;
UNII	S0W1V6314Y ;
CompTox Dashboard (EPA)	DTXSID80156337 ;
	InChI InChI=1S/CH3N3O2/c2-1(5)3-4-6/h(H3,2,3,5,6) Key: OSTGTTZJOCZWJG-UHFFFAOYSA-N ;
	SMILES NC(=O)N=NO; C(=O)(N)NN=O;
Properties
Chemical formula	CH3N3O2
Molar mass	89.054 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	Infobox references

Nitrosourea is both the name of a molecule, and a class of compounds that include a nitroso (R-NO) group and a urea.

Examples

Examples include:

Arabinopyranosyl-N-methyl-N-nitrosourea (Aranose)
Carmustine (BCNU, BiCNU)
Chlorozotocin
Ethylnitrosourea (ENU)
Fotemustine
Lomustine (CCNU)
Nimustine
N-Nitroso-N-methylurea (NMU)
Ranimustine (MCNU)
Semustine
Streptozocin (Streptozotocin)

Nitrosourea compounds are DNA alkylating agents and are often used in chemotherapy.[1] They are lipophilic and thus can cross the blood–brain barrier, making them useful in the treatment of brain tumors such as glioblastoma multiforme.[2]

Side effects

Some nitrosoureas (e.g. lomustine) have been associated with the development of interstitial lung disease.[3]

gollark: <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016> <:Thonk:445016973798014987> <:Thonkdown:433149076721238016>

References

"Antineop". Archived from the original on 2009-03-07. Retrieved 2009-01-24.
Takimoto CH, Calvo E. "Principles of oncologic pharmacotherapy". in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer management: a multidisciplinary approach. 11 ed. 2008.
Tucci E, Verdiani P, Di Carlo S, Sforza V (1986). "Lomustine (CCNU)-induced pulmonary fibrosis". Tumori. 72 (1): 95–8. PMID 3952821.

External links

Nitrosourea+Compounds at the US National Library of Medicine Medical Subject Headings (MeSH)
DDB 9052

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[urlantineop-1] "Antineop". Archived from the original on 2009-03-07. Retrieved 2009-01-24.

[2] Takimoto CH, Calvo E. "Principles of oncologic pharmacotherapy". in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer management: a multidisciplinary approach. 11 ed. 2008.

[3] Tucci E, Verdiani P, Di Carlo S, Sforza V (1986). "Lomustine (CCNU)-induced pulmonary fibrosis". Tumori. 72 (1): 95–8. PMID 3952821.